It also provides this data summarized for the whole country
Most patients (93%) tolerate side effects well enough to continue treatment
The analysis highlighted the impact on the food and beverage industry, with GLP-1 user households found to have spent 780 million less on groceries overall during the study period
In addition, a meta-analysis of the HARMONY studies of albiglutide revealed that the risk of cardiovascular events was not significantly higher in subjects on albiglutide than in subjects on all other comparators including placebo and oral antidiabetic drugs such as glimepiride, insulin glargine, insulin lispro, liraglutide, pioglitazone, and sitagliptin [99]
Lin H, Liu J, Hou Y, Yu Z, Hong J, Yu J, et al